抗Ro抗体血清阳性与成人心律及传导障碍的关联
抗Ro血清阳性者传导障碍发生率3.0% vs 1.7%,心律障碍10.5% vs 7.0%,多因素回归显示传导障碍OR 1.44(95%CI 1.25-1.66),心律障碍OR 1.21(95%CI 1.11-1.31)。
要点
- 抗Ro血清阳性与成人心脏传导障碍风险升高独立相关(OR 1.44)。
- 抗Ro血清阳性与心律障碍的关联较弱(OR 1.21)。
- 单纯抗La阳性未显示与心律失常显著相关。
核心结论
- 抗Ro血清阳性与成人心脏传导障碍正相关,与心律障碍关联较弱,且不依赖于是否合并自身免疫病。
主要发现
- 抗Ro血清阳性者传导障碍发生率为3.0%,对照组为1.7%(P < 0.001)。
- 抗Ro血清阳性者心律障碍发生率为10.5%,对照组为7.0%(P < 0.001)。
- 单纯抗La阳性未显示与心律失常显著相关。
- 多因素logistic回归显示抗Ro血清阳性者传导障碍OR 1.44(95%CI 1.25-1.66,P < 0.001),心律障碍OR 1.21(95%CI 1.11-1.31,P < 0.001)。
临床怎么用
- 对成人心内科患者,若抗Ro血清阳性,应关注传导障碍和心律障碍的筛查与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Anti-Ro/La autoantibodies are especially prevalent in autoimmune diseases but are also relatively frequent in healthy adults. Their arrhythmogenic effect on the immature cardiac conductive system is well established, with substantial evidence demonstrating an increased risk for congenital atrioventricular block in neonates of seropositive mothers. Despite their wide distribution and their arrhythmogenic potential effect, there are no large population studies conducted in seropositive adults. Thus, this is the first large population-based study to examine the association of anti-Ro/La seropositivity with cardiac rhythm and conduction disturbances. METHODS AND RESULTS: This cross-sectional designed study involved the electronic health records of the largest health maintenance organization in Israel. All subjects that were tested positive for anti-Ro/anti-La antibodies between the years 2002 and 2019 were included and were matched by age, gender, and place of residence, with controls. Rates of different cardiac rhythm and conduction disturbances were compared between groups. Sensitivity analyses were performed using propensity score matching. The study population included 17 231 anti-Ro/La seropositive subjects and 84 368 controls. Anti-Ro seropositive patients had higher rates of conduction disturbances (3.0 vs. 1.7%, P < 0.001) and rhythm disturbances (10.5 vs. 7.0%, P < 0.001). Patients who tested positive for anti-La alone did not demonstrate a significant association with arrhythmias. Multivariate logistic regression analysis, controlling for possible confounders, showed an increased risk for cardiac conduction disturbances [odds ratio (OR) 1.44, 95% confidence interval (CI) 1.25-1.66, P < 0.001], as well as for cardiac rhythm disturbances (OR 1.21, 95% CI 1.11-1.31, P < 0.001) among anti-Ro seropositive patients. However, the association with rhythm disturbances was more robust in certain subgroup analyses. CONCLUSIONS: Anti-Ro seropositivity is positively associated with adult cardiac conduction disturbances and, to a lesser extent, cardiac rhythm disturbances, regardless of the presence of concurrent autoimmune disease.
引用
- Akuka A, Ben-Shabat N, Watad A, et al. Association of anti-Ro seropositivity with cardiac rhythm and conduction disturbances. Eur Heart J. 2022. PMID: 36148481. doi:10.1093/eurheartj/ehac516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。